JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HARRIS, P. N.
Right arrow Articles by CHEN, K. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by HARRIS, P. N.
Right arrow Articles by CHEN, K. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 79, Issue 2, 133-135, 1943
Copyright © 1943 by American Society for Pharmacology and Experimental Therapeutics

THE ACTION OF CARTHAMOIDINE

PAUL N. HARRIS 1, ROBERT C. ANDERSON 1, and K. K. CHEN 1

1 From the Lilly Research Laboratories, Eli Lilly and Company, Indianapolis

Carthamoidine in suitable doses produces slow death and necrosis of the liver in mice when injected intravenously. The lesion is predominantly periportal, similar to that caused by pterophine. Carthamoidine inhibits the isolated rabbit's intestines, stimulates the isolated guinea pig's uterus, and lowers blood pressure in etherized cats.

Submitted on June 30, 1943






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1943 by the American Society for Pharmacology and Experimental Therapeutics.